PURPLE BIOTECH LTD. Fee And Commission Expense
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FeeAndCommissionExpense · last filed 2026-03-19
| Period end | Fee And Commission Expense 12 month |
|---|---|
| 2025-12-31 | $39.00K 20-F · filed 2026-03-19 |
| 2024-12-31 | $41.00K 20-F · filed 2026-03-19 |
| 2023-12-31 | $56.00K 20-F · filed 2026-03-19 |
| 2022-12-31 | $67.00K 20-F · filed 2025-03-10 |
| 2021-12-31 | $79.00K 20-F · filed 2024-03-05 |
| 2020-12-31 | $56.00K 20-F · filed 2023-03-03 |
| 2019-12-31 | $81.00K 20-F · filed 2022-03-09 |
| 2018-12-31 | $9.00K 20-F · filed 2021-03-16 |
| 2017-12-31 | $26.00K 20-F · filed 2020-03-23 |
| 2016-12-31 | $6.00K 20-F · filed 2019-03-26 |
| 2015-12-31 | $3.00K 20-F · filed 2018-03-05 |